Bruno H. Pypendop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bruno H. Pypendop has a total of 300 co-authors. Here are the top co-authors by number of shared publications:
Jan E. Ilkiw
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA
29 shared publicationsLinda S. Barter
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA
14 shared publicationsJ. E. Ilkiw
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA
11 shared publicationsKristine T. Siao
Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA, USA
11 shared publicationsS. D. Stanley
California Animal Health and Food Safety Laboratory System School of Veterinary Medicine University of California Davis CA USA
8 shared publicationsJuhana Honkavaara
Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA, USA
7 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
Pharmacokinetics of Detomidine and Vatinoxan in Horses
The pharmacokinetics of detomidine, vatinoxan, and their combination have not been previously characterized in detail in horses. Detomidine (20 μg/kg), vatinoxan (200 μg/kg), or their combination was administered intravenously to six horses according to a Latin square design. Blood was sampled at various times up to 480 min following administration. Plasma concentrations of detomidine, OH‐detomidine, COOH‐detomidine, and vatinoxan were measured using liquid chromatography/tandem mass spectrometry. Compartmental models were fitted to the time‐concentration data using nonlinear mixed‐effect modeling. A 5‐compartment model provided the best fit for detomidine and its metabolites, whereas the disposition of vatinoxan was best described by a 3‐compartment model. The volume of distribution at steady state was 762 mL/kg for detomidine and 1422 mL/kg for vatinoxan. Total metabolic clearance was 21.6 mL/min/kg for detomidine and 7.1 mL/min/kg for vatinoxan. Clearance of detomidine into OH‐detomidine and of OH‐detomidine into COOH‐detomidine was predicted to be 40 and 7% of their respective clearance. Covariates accounting for the effect of vatinoxan on several parameters improved the model, suggesting that administration of vatinoxan affects the disposition of detomidine. Similarly, covariates suggested that administration of detomidine affects the disposition of vatinoxan.
- 29 October 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
Open AccessPharmacokinetics of Detomidine and Vatinoxan in Horses
The pharmacokinetics of detomidine, vatinoxan, and their combination have not been previously characterized in detail in horses. Detomidine (20 μg/kg), vatinoxan (200 μg/kg), or their combination was administered intravenously to six horses according to a Latin square design. Blood was sampled at various times up to 480 min following administration. Plasma concentrations of detomidine, OH‐detomidine, COOH‐detomidine, and vatinoxan were measured using liquid chromatography/tandem mass spectrometry. Compartmental models were fitted to the time‐concentration data using nonlinear mixed‐effect modeling. A 5‐compartment model provided the best fit for detomidine and its metabolites, whereas the disposition of vatinoxan was best described by a 3‐compartment model. The volume of distribution at steady state was 762 mL/kg for detomidine and 1422 mL/kg for vatinoxan. Total metabolic clearance was 21.6 mL/min/kg for detomidine and 7.1 mL/min/kg for vatinoxan. Clearance of detomidine into OH‐detomidine and of OH‐detomidine into COOH‐detomidine was predicted to be 40 and 7% of their respective clearance. Covariates accounting for the effect of vatinoxan on several parameters improved the model, suggesting that administration of vatinoxan affects the disposition of detomidine. Similarly, covariates suggested that administration of detomidine affects the disposition of vatinoxan.
- Open Access
- 26 February 2026
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 53 (3) , 101216
Investigating the effect of surface cryotherapy on equine patient compliance to infraorbital nerve block placement
- 26 February 2026
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 53 (3) , 101216
Open AccessInvestigating the effect of surface cryotherapy on equine patient compliance to infraorbital nerve block placement
- Open Access
- 31 January 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (3) , 289-294
Exposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan
The aim of the study was to determine the exposure to subcutaneously administered butorphanol in horses pre‐treated with intravenous (IV) detomidine, with or without vatinoxan, a peripherally selective alpha 2 ‐adrenoceptor antagonist. Five healthy, adult horses received three IV treatments 7 days apart, in a randomized, cross‐over design: detomidine 20 μg/kg (DET‐B), detomidine 20 μg/kg with vatinoxan 200 μg/kg (DETVAT‐B) and saline (S‐B), all followed by 0.1 mg/kg of butorphanol administered subcutaneously 30 min later. Venous samples were collected between 10 and 270 min after butorphanol administration. Butorphanol concentrations in plasma were analyzed with liquid chromatography coupled with triple quadruple mass spectrometry. Data were analyzed with non‐compartmental methods. The observed areas under plasma butorphanol concentration‐time curves were 8104 ± 2590, 7042 ± 2628 and 5996 ± 1670 ng·min/mL for DET‐B, DETVAT‐B and S‐B, respectively. There were no significant differences between treatments. Pre‐treatment with detomidine, with or without vatinoxan, did not significantly affect the exposure to subcutaneously administered butorphanol in this study.
- 31 January 2026
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (3) , 289-294
Open AccessExposure to Subcutaneously Administered Butorphanol in Horses Pre‐Treated With Detomidine or Detomidine‐Vatinoxan
The aim of the study was to determine the exposure to subcutaneously administered butorphanol in horses pre‐treated with intravenous (IV) detomidine, with or without vatinoxan, a peripherally selective alpha 2 ‐adrenoceptor antagonist. Five healthy, adult horses received three IV treatments 7 days apart, in a randomized, cross‐over design: detomidine 20 μg/kg (DET‐B), detomidine 20 μg/kg with vatinoxan 200 μg/kg (DETVAT‐B) and saline (S‐B), all followed by 0.1 mg/kg of butorphanol administered subcutaneously 30 min later. Venous samples were collected between 10 and 270 min after butorphanol administration. Butorphanol concentrations in plasma were analyzed with liquid chromatography coupled with triple quadruple mass spectrometry. Data were analyzed with non‐compartmental methods. The observed areas under plasma butorphanol concentration‐time curves were 8104 ± 2590, 7042 ± 2628 and 5996 ± 1670 ng·min/mL for DET‐B, DETVAT‐B and S‐B, respectively. There were no significant differences between treatments. Pre‐treatment with detomidine, with or without vatinoxan, did not significantly affect the exposure to subcutaneously administered butorphanol in this study.
- Open Access
- 3 June 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12, 1600753
Target-controlled infusions of butorphanol worsen hemodynamics in isoflurane-anesthetized cats
Introduction: Partial intravenous anesthesia can be used to reduce the adverse effects of inhalant anesthetics, and opioids are often used in this context in dogs and cats. The opioid butorphanol was recently shown to dose-dependently reduce the minimum alveolar concentration of isoflurane in cats. The aim of this study was to characterize the hemodynamic effects of butorphanol in isoflurane-anesthetized cats.Methods: Six cats were anesthetized with isoflurane and administered butorphanol to maintain target plasma concentrations (TPCs) of 0, 1.1, 2.2 and 4.4 μg mL−1, with or without concurrent administration of atropine. The isoflurane concentration was adjusted to maintain equipotency based on the results of a previous study. Cardiorespiratory variables were measured at each plasma butorphanol concentration.Results: Severe bradycardia and hypotension were observed in one cat at the 4.4 μg mL−1 TPC and in one cat at the 2.2 μg mL−1 TPC without atropine. Treatments without atropine and the 4.4 μg mL−1 TPC were not studied in subsequent cats. Butorphanol significantly reduced heart rate, cardiac index and oxygen delivery index, and increased systemic vascular resistance index and oxygen consumption index in a plasma concentration-dependent manner.Discussion: In isoflurane-anesthetized cats, at the TPCs studied, butorphanol caused more cardiovascular depression than a higher, equipotent concentration of isoflurane alone.
- 3 June 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12, 1600753
Open AccessTarget-controlled infusions of butorphanol worsen hemodynamics in isoflurane-anesthetized cats
Introduction: Partial intravenous anesthesia can be used to reduce the adverse effects of inhalant anesthetics, and opioids are often used in this context in dogs and cats. The opioid butorphanol was recently shown to dose-dependently reduce the minimum alveolar concentration of isoflurane in cats. The aim of this study was to characterize the hemodynamic effects of butorphanol in isoflurane-anesthetized cats.Methods: Six cats were anesthetized with isoflurane and administered butorphanol to maintain target plasma concentrations (TPCs) of 0, 1.1, 2.2 and 4.4 μg mL−1, with or without concurrent administration of atropine. The isoflurane concentration was adjusted to maintain equipotency based on the results of a previous study. Cardiorespiratory variables were measured at each plasma butorphanol concentration.Results: Severe bradycardia and hypotension were observed in one cat at the 4.4 μg mL−1 TPC and in one cat at the 2.2 μg mL−1 TPC without atropine. Treatments without atropine and the 4.4 μg mL−1 TPC were not studied in subsequent cats. Butorphanol significantly reduced heart rate, cardiac index and oxygen delivery index, and increased systemic vascular resistance index and oxygen consumption index in a plasma concentration-dependent manner.Discussion: In isoflurane-anesthetized cats, at the TPCs studied, butorphanol caused more cardiovascular depression than a higher, equipotent concentration of isoflurane alone.
- Open Access
- 30 January 2025
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (3) , 284-292
Pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered cats
- 30 January 2025
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (3) , 284-292
Open AccessPharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered cats
- Open Access
- 8 December 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (2) , 161-173
Characterization of the anesthetic effects of dexmedetomidine–vatinoxan–ketamine combinations in cats
- 8 December 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (2) , 161-173
Open AccessCharacterization of the anesthetic effects of dexmedetomidine–vatinoxan–ketamine combinations in cats
- Open Access
- 8 November 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (1) , 90-97
Effect of buprenorphine delivered by target-controlled infusion on the minimum alveolar concentration of isoflurane in cats
- 8 November 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (1) , 90-97
Open AccessEffect of buprenorphine delivered by target-controlled infusion on the minimum alveolar concentration of isoflurane in cats
- Open Access
- 1 November 2024
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 262 (11) , 1-7
Successful use of ultrasound guided pecto-intercostal fascial plane block to provide intraoperative analgesia in four dogs undergoing median sternotomy
OBJECTIVE: To evaluate the impact of pecto-intercostal fascial plane block on providing intraoperative analgesia in dogs undergoing median sternotomy. ANIMALS: 4 dogs. CLINICAL PRESENTATION: The dogs were presented with a history of inappetence, lethargy and respiratory distress. Thoracic radiographs, point of care ultrasound, thoracocentesis, bronchoscopy and computed tomography was performed to characterize the disease. RESULTS: 4 male castrated, 5.3 ± 3 years old dogs weighing 19.7 ± 13.5 kg and belonging to Dalmatian, Beagle, Siberian Husky and Rottweiler breeds were included. Three dogs were diagnosed with suppurative pleural effusions because of pulmonary abscesses and one dog with spontaneous pneumothorax due to the presence of pulmonary bullae. All dogs underwent median sternotomy under general anesthesia to explore the thorax. A pecto-intercostal fascial plane block was performed by injecting local anesthetic bupivacaine in the parasternal fascial plane between the deep pectoral and external intercostal muscles to provide antinociception by anesthetizing ventral cutaneous branches of intercostal nerves second through sixth. Analgesia from the block resulted in reduced requirement of inhalant anesthesia and minimal requirement for opioid to augment analgesia intraoperatively. CLINICAL RELEVANCE: Median sternotomy is required to perform thoracic surgery in dogs with various thoracic pathologies. Pecto-intercostal fascial plane block is a locoregional technique that can blunt nociception arising from the ventral thorax and can significantly improve perioperative patient care in dogs undergoing median sternotomy by providing effective intraoperative and potentially postoperative analgesia.
- 1 November 2024
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 262 (11) , 1-7
Open AccessSuccessful use of ultrasound guided pecto-intercostal fascial plane block to provide intraoperative analgesia in four dogs undergoing median sternotomy
OBJECTIVE: To evaluate the impact of pecto-intercostal fascial plane block on providing intraoperative analgesia in dogs undergoing median sternotomy. ANIMALS: 4 dogs. CLINICAL PRESENTATION: The dogs were presented with a history of inappetence, lethargy and respiratory distress. Thoracic radiographs, point of care ultrasound, thoracocentesis, bronchoscopy and computed tomography was performed to characterize the disease. RESULTS: 4 male castrated, 5.3 ± 3 years old dogs weighing 19.7 ± 13.5 kg and belonging to Dalmatian, Beagle, Siberian Husky and Rottweiler breeds were included. Three dogs were diagnosed with suppurative pleural effusions because of pulmonary abscesses and one dog with spontaneous pneumothorax due to the presence of pulmonary bullae. All dogs underwent median sternotomy under general anesthesia to explore the thorax. A pecto-intercostal fascial plane block was performed by injecting local anesthetic bupivacaine in the parasternal fascial plane between the deep pectoral and external intercostal muscles to provide antinociception by anesthetizing ventral cutaneous branches of intercostal nerves second through sixth. Analgesia from the block resulted in reduced requirement of inhalant anesthesia and minimal requirement for opioid to augment analgesia intraoperatively. CLINICAL RELEVANCE: Median sternotomy is required to perform thoracic surgery in dogs with various thoracic pathologies. Pecto-intercostal fascial plane block is a locoregional technique that can blunt nociception arising from the ventral thorax and can significantly improve perioperative patient care in dogs undergoing median sternotomy by providing effective intraoperative and potentially postoperative analgesia.
- 18 August 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 51 (6) , 713-720
Ultrasound-guided trigeminal nerve approach at the level of the pterygopalatine fossa in cat cadavers
- 18 August 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 51 (6) , 713-720
Ultrasound-guided trigeminal nerve approach at the level of the pterygopalatine fossa in cat cadavers
- Open Access
- 14 August 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 51 (6) , 641-649
Correlation, agreement and concordance of cardiac output estimated by transthoracic ultrasound and transesophageal Doppler with pulmonary artery thermodilution in anesthetized cats
- 14 August 2024
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 51 (6) , 641-649
Open AccessCorrelation, agreement and concordance of cardiac output estimated by transthoracic ultrasound and transesophageal Doppler with pulmonary artery thermodilution in anesthetized cats